Monoclonal Antibody Risankizumab for Ulcerative Colitis

JAMA. 2024 Sep 17;332(11):877-878. doi: 10.1001/jama.2024.8819.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal* / adverse effects
  • Antibodies, Monoclonal* / therapeutic use
  • Colitis, Ulcerative* / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal
  • risankizumab